Therapeutic targeting of the DNA damage mediators CHK1 and Wee1 in neuroblastoma

被引：0

作者：

Russell, Mike ^{[1
]}

Levin, Kirill ^{[1
]}

Rader, JulieAnn ^{[1
]}

Toniatti, Carlo ^{[2
]}

Maris, John M. ^{[1
]}

Cole, Kristina A. ^{[1
]}

机构：

[1] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA

[2] Merck Res Labs, Boston, MA USA

来源：

CANCER RESEARCH | 2012年 / 72卷

关键词：

D O I：

10.1158/1538-7445.AM2012-1436

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1436

引用

页数：1

共 50 条

[31] NEW INSIGHTS INTO MK 1775 RESISTANCE: DUAL INHIBITION OF WEE1 AND CHK1 IN UGC TREATMENT [J].

Thangaretnam, K. ;

Islam, M. O. ;

Lu, H. ;

Peng, D. ;

Bhat, N. ;

Soutto, M. ;

El-Rifai, Wael ;

Chen, Z. .

GASTROENTEROLOGY, 2024, 166 (05) :S689-S689

[32] Targeting the Cell Cycle Checkpoints CHK1 and CHK2 is a Novel Therapeutic Approach for Pediatric Neuroblastoma [J].

Morrison, Ben ;

Chilamakuri, Rameswari ;

Agarwal, Saurabh .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 385

[33] TARGETING CELL CYCLE S-PHASE STABILITY BY THE CONCOMITANT INHIBITION OF CHK1 AND WEE1 KINASES IN ACUTE LYMPHOBLASTIC LEUKEMIA [J].

Luserna Di Rora, A. Ghelli ;

Ferrari, A. ;

Bocconcelli, M. ;

Imbrogno, E. ;

Robustelli, V. ;

Papayannidis, C. ;

Abbenante, M. C. ;

Marconi, G. ;

Nanni, J. ;

Parisi, S. ;

Sartor, C. ;

Paolini, S. ;

Cavo, M. ;

Martinelli, G. .

HAEMATOLOGICA, 2018, 103 :S103-S104

[34] A siRNA high-throughput screening identified Wee1 as determinant of Chk1 inhibitor sensitivity [J].

Carrassa, Laura ;

Chila, Rosaria ;

Lupi, Monica ;

Ricci, Francesca ;

Mazzoletti, Marco ;

Celenza, Cinzia ;

Broggini, Massimo ;

Damia, Giovanna .

CANCER RESEARCH, 2012, 72

[35] Synthetic lethal combination of CHK1 and WEE1 inhibition for treatment of castration-resistant prostate cancer [J].

Yapeng Chao ;

Yuzhou Chen ;

Wenxiao Zheng ;

Kathryn Demanelis ;

Yu Liu ;

Jaclyn A. Connelly ;

Hong Wang ;

Song Li ;

Qiming Jane Wang .

Oncogene, 2024, 43 :789-803

[36] Targeting Wee1 kinase as a therapeutic approach in Hematological Malignancies [J].

Vakili-Samiani, Sajjad ;

Jalil, Abduladheem Turki ;

Abdelbasset, Walid Kamal ;

Yumashev, Alexei Valerievich ;

Karpisheh, Vahid ;

Jalali, Pooya ;

Adibfar, Sara ;

Ahmadi, Majid ;

Feizi, Abbas Ali Hosseinpour ;

Jadidi-Niaragh, Farhad .

DNA REPAIR, 2021, 107

[37] Combined inhibition of Chk1 and Wee1 In vitro synergistic effect translates to tumor growth inhibition in vivo [J].

Carrassa, Laura ;

Chila, Rosaria ;

Lupi, Monica ;

Ricci, Francesca ;

Celenza, Cinzia ;

Mazzoletti, Marco ;

Broggini, Massimo ;

Damia, Giovanna .

CELL CYCLE, 2012, 11 (13) :2507-2517

[38] Overcoming MK1775 resistance in upper gastrointestinal cancers with combined WEE1 and CHK1 inhibition [J].

Thangaretnam, Krishnapriya ;

Islam, Md Obaidul ;

Lu, Heng ;

Peng, Dunfa ;

Bhat, Nadeem Sidiq ;

Soutto, Mohammed ;

Wael, EL-Rifai ;

Chen, Zheng .

CANCER RESEARCH, 2024, 84 (06)

[39] Safeguarding genome integrity: the checkpoint kinases ATR, CHK1 and WEE1 restrain CDK activity during normal DNA replication [J].

Sorensen, Claus Storgaard ;

Syljuasen, Randi G. .

NUCLEIC ACIDS RESEARCH, 2012, 40 (02) :477-486

[40] Inhibition of checkpoint kinase 1 (Chk1) as a potential therapeutic for pediatric neuroblastoma [J].

Russell, Mike R. ;

Cole, Kristina A. ;

Maris, John M. .

CANCER RESEARCH, 2011, 71

← 1 2 3 4 5 →